Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.2400
0.0000
(0.00%)
At close: February 26 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 1.5M | 1.2M | 6.3M | 2.8M |
| Low Estimate | 1.5M | 1.2M | 6.3M | 2.8M |
| High Estimate | 1.5M | 1.2M | 6.3M | 2.8M |
| Year Ago Sales | 900k | 1.1M | 4.2M | 6.3M |
| Sales Growth (year/est) | 66.67% | 9.09% | 50.00% | -55.56% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NICXF | -- | -- | -- | -- |
| S&P 500 | 15.59% | 7.50% | 10.67% | 14.09% |
Related Tickers
430.BE Terns Pharmaceuticals Inc
3.6000
+1.12%
ANL Adlai Nortye Ltd.
2.2203
+0.92%
TRDA Entrada Therapeutics, Inc.
12.02
-0.83%
CGEM Cullinan Therapeutics, Inc.
8.45
-1.29%
IMCR Immunocore Holdings plc
30.77
+5.34%
MNPR Monopar Therapeutics Inc.
31.29
+0.58%
AGIO Agios Pharmaceuticals, Inc.
34.44
-2.13%
BRTX BioRestorative Therapies, Inc.
1.9100
+4.95%
HEPA Hepion Pharmaceuticals, Inc.
0.1560
+1.83%
PTGX Protagonist Therapeutics, Inc.
36.15
+3.02%